Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
307.60    -11.20 (-3.51%)
Bid:
313.60
Ask:
315.00
Spread: 1.40 (0.446%)
Market Cap: £673.86m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Sterling FX Rate for 2020 Final Dividend

8 Jun 2021 12:00

RNS Number : 1600B
Burford Capital Limited
08 June 2021
 

 

 

8 June 2021

 

 

STERLING CONVERSION RATE FOR 2020 FINAL DIVIDEND

 

Burford Capital Limited, the leading global finance and asset management firm focused on law, announces the Sterling exchange rate for its previously approved 2020 final dividend of 12.5 US cents per ordinary share to be paid on June 18, 2021, to shareholders on record as of May 28, 2021.

 

For shareholders electing to receive their dividend in Sterling, the final dividend is 8.817720 pence per ordinary share, based on the exchange rate of £1 = US$1.4176 set on May 28, 2021.

 

 

For further information, please contact:

 

Burford Capital Limited

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Kevin Cruickshank (NOMAD)

Charlie Farquhar / Jonathan Abbott (Joint Broker)

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information, please visit www.burfordcapital.com.

 

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934 regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, we and our representatives may from time to time make other oral or written statements which are forward-looking statements, including in our periodic reports that we file with the US Securities and Exchange Commission, other information sent to our security holders, and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and are based on numerous assumptions and that our actual results of operations, including our financial condition and liquidity and the development of the industry in which we operate, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this announcement. Significant factors that may cause actual results to differ from those we expect include those discussed under "Risk Factors" in our Annual Report on Form 20-F filed with the US Securities and Exchange Commission on March 24, 2021. In addition, even if our results of operations, including our financial condition and liquidity and the development of the industry in which we operate, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

 

Except as required by law, we undertake no obligation to update or revise the forward-looking statements contained in this announcement, whether as a result of new information, future events, a change in our views or expectations or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAPKPESSFEEA
Date   Source Headline
3rd Jul 202511:00 amRNSIssue of New Shares in Connection With LTIP
2nd Jul 20255:30 pmRNSHolding(s) in Company
1st Jul 20255:46 pmRNSUS Budget Bill Adopted Without Lit Fin Provisions
1st Jul 20257:15 amRNSUpdate Re US Budget Bill and YPF Ruling
30th Jun 20258:00 amRNSFurther Statement Re US Budget Reconciliation Bill
30th Jun 20257:00 amRNSChange of Nominated Adviser
17th Jun 20257:00 amRNSStatement Re US Budget Reconciliation Bill
10th Jun 20251:00 pmRNSIssue of Equity & Director/PDMR Shareholding
6th Jun 202511:30 amRNSCompleted Purchases of Shares
5th Jun 20251:00 pmRNSIntended Purchases of Ordinary Shares
30th May 202512:00 pmRNSSterling FX Rate for 2024 Final Dividend
16th May 20251:30 pmRNSDirector/PDMR Shareholding
15th May 20251:00 pmRNSResult of AGM
14th May 202512:37 pmRNSMSCI Change to BUR Index Country Classification
7th May 20251:00 pmRNS1Q25 Financial Results
6th May 202512:00 pmRNSNotice of Retail Shareholder Audio Webcast
30th Apr 202512:00 pmRNSNotice of 1Q25 Results & Results Call Details
28th Apr 202512:00 pmRNSAdditional Definitive Proxy Soliciting Materials
10th Apr 202512:00 pmRNSIssue of Equity & Director/PDMR Shareholding
4th Apr 20257:00 amRNSDefinitive Proxy Materials and 2024 Annual Report
3rd Apr 202512:00 pmRNSStrategic Update at 2025 Investor Day
17th Mar 202511:00 amRNSPartial Repurchase and Cancellation of Bonds
17th Mar 202511:00 amRNSIntended Purchases of Ordinary Shares
11th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSFiling of 2024 Annual Report on Form 10-K
3rd Mar 202512:00 pmRNSAnnual Results for Year Ended December 31, 2024
25th Feb 20257:00 amRNSNotice of 2024 Results & Reporting Change Preview
4th Feb 20252:00 pmRNSBurford Capital announces 2025 Investor Day
31st Jan 20257:30 amRNSDirector/PDMR Shareholding
27th Dec 202411:00 amRNSIssue of New Shares in Connection With LTIP
17th Dec 202411:00 amRNSDirector/PDMR Shareholding
22nd Nov 202412:00 pmRNSDirector/PDMR Shareholding
15th Nov 20241:15 pmRNSPartial Repurchase and Cancellation of Bonds
8th Nov 202412:00 pmRNSSterling Conversion Rate for 2024 Interim Dividend
7th Nov 202412:46 pmRNS3Q24 Results & Quarterly Report
7th Nov 202412:03 pmRNSBurford Statement re YPF Matter
28th Oct 202412:00 pmRNSNotice of 3Q24 Results & Results Call Details
17th Oct 202411:00 amRNS2025 AGM Logistics
1st Oct 202411:00 amRNSDirector/PDMR Shareholding
25th Sep 20241:15 pmRNSIssue of New Shares in Connection With LTIP
23rd Aug 202412:00 pmRNSResult of Meeting
23rd Aug 202411:30 amRNSDirector/PDMR Shareholding
21st Aug 202411:00 amRNSDirector/PDMR Shareholding
8th Aug 202412:00 pmRNS2Q24 Results & Quarterly Report
5th Aug 202412:00 pmRNSTransition to US Domestic Issuer Status
31st Jul 202412:00 pmRNSNotice of 2Q24 Results & Results Call Details
22nd Jul 202412:00 pmRNSNotice of EGM
10th Jul 20247:00 amRNSAppointment of KPMG LLP as Independent Auditor
2nd Jul 202411:00 amRNSHolding(s) in Company
28th Jun 202412:00 pmRNSIssue of New Shares for LTIP & Adjusted PDMR LTIP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.